BRODOSI, LUCIA
BRODOSI, LUCIA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Ricercatori a tempo determinato
A modified Child-Turcotte-Pugh (CTP) for selection of candidates to liver transplantation (LT) with low model for end-stage liver disease score (MELD).
2010 S. Gitto, M. Biselli, A. Gramenzi, R. Di Donato, L. Brodosi, G. Vitale, S. Lorenzini, M. Ravaioli, G. Grazi, A.D. Pinna, M. Bernardi, P. Andreone.
A modified Child-Turcotte-Pugh (CTP) for selection of patients affected by cirrhosis candidates for liver transplantation (LT) with low model for end-stage liver disease score (MELD)
2010 S. Gitto, M. Biselli, A. Gramenzi, L. Brodosi, R. Di Donato, G. Vitale, S. Lorenzini, M. Ravaioli, G. Grazi, A.D. Pinna, M. Bernardi, P. Andreone
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18.
2015 Biselli M; Dall’Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M.
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report.
2014 Gamal N; Brodosi L; Misciali C; Patrizi A; Vukatana G; Malavolta N; Bernardi M; Andreone P.
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers
2018 Mazzotti, Arianna; Caletti, Maria Turchese; Brodosi, Lucia; Di Domizio, Silvia; Forchielli, Maria Luisa; Petta, Salvatore; Bugianesi, Elisabetta; Bianchi, Giampaolo; Marchesini, Giulio*
Bone marrow derived stem cells for the treatment of end-stage liver disease.
2014 Margini C; Vukotic R; Brodosi L; Bernardi M; Andreone P.
Capitolo 14 "Epatiti Virali Croniche", Volume IX "Malattie del Fegato, delle Vie Biliari e del Pancreas", Trattato di Medicina Interna, fondato da Paolo Larizza
2010 A. Gramenzi; S. Lorenzini; L. Brodosi; P. Andreone
CD 133+ stem cells for the treatment of end stage liver disease.
2012 L. Brodosi; L. Catani; S. Lorenzini; R. Giordano; S. Rizzi; V. Giudice; D. Sollazzo; B. Nicolini; E. Montelatici; T. Montemurro; E. Dan; E. Massari; M. Baccarani; M. Bernardi; R. M. Lemoli; P. Andreone.
CD133+ hematopoietic stem cells reinfusion in end-stage liver disease (ESLD): final results of a phase I clinical trial
2014 C. Margini, L. Brodosi, S. Lorenzini, L. Catani, V. Giudice, R. Giordano, A. Casadei, D. Sollazzo, F.G. Foschi, M. Baccarani, M. Bernardi, R. Lemoli, P. Andreone
CD133+ stem cells for the treatment of end-stage liver disease
2012 L. Brodosi, L. Catani, S. Lorenzini, R. Giordano, S. Rizzi, V. Giudice, D. Sollazzo, B. Nicolini, E. Montelatici, T. Montemurro, E. Dan, E. Massari, M. Baccarani, M. Bernardi, R.M. Lemoli, P. Andreone
COMBINATION study: COMbined Behavioural/INcretin Action sTudy In Obese/diabetic persoNs
2018 L. Montesi, A. Mazzotti, L. Brodosi, MT Caletti, FA Barbanti, P. Di Bartolo, G. Marchesini
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease
2022 Brodosi L.; Marchignoli F.; Marchesini G.; Petroni M.L.
Dati preliminari sullo studio della sintomatologia ortoressica tra pazienti diabetici affetti da epatopatia.
2020 Brodosi L, Simonetti G, Musio A, Petroni M.L, Gentile A, Genovese M, Marchesini G, Pironi L
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects.
2013 G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, E. Loggi, A.F. Cicero, M. Bernardi, P. Andreone
Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential
2020 Brodosi, Lucia; Musio, Alessandra; Barbanti, Francesca Alessandra; Mita, Dorina; Marchesini, Giulio; Petroni, Maria Letizia
Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant)
2021 Brodosi L, Mita D, Simonetti G, Vitale G, Gentile A, Genovese M, Marchesini G, Morelli MC, Pironi L.
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis
2021 Colosimo, Santo; Ravaioli, Federico; Petroni, Maria L; Brodosi, Lucia; Marchignoli, Francesca; Barbanti, Francesca A; Sasdelli, Anna S; Marchesini, Giulio; Pironi, Loris
Fatty liver in pregnancy: a narrative review of two distinct conditions
2020 Azzaroli, Francesco; Mazzella, Giuseppe; Marchesini, Giulio; Brodosi, Lucia; Petroni, Maria Letizia
Hepatitis C recurrence after liver transplantation: do patients with mild disease need to be treated?
2012 S. Gitto, L.S. Belli, S. Lorenzini, A. Airoldi, A.F. Cicero, M. Vangeli, L. Brodosi, A.M. Panno, R. Di Donato, M. Bernardi, P. Andreone, P
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation.
2015 Gitto S; Belli LS; Vukotic R; Lorenzini S; Airoldi A; Cicero AF; Vangeli M; Brodosi L; Martello Panno A; Di Donato R; Cescon M; Grazi GL; De Carlis L; Pinna AD; Bernardi M; Andreone P.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A modified Child-Turcotte-Pugh (CTP) for selection of candidates to liver transplantation (LT) with low model for end-stage liver disease score (MELD). | S. Gitto, M. Biselli, A. Gramenzi, R. Di Donato, L. Brodosi, G. Vitale, S. Lorenzini, M. Ravaioli..., G. Grazi, A.D. Pinna, M. Bernardi, P. Andreone. | 2010-01-01 | DIGESTIVE AND LIVER DISEASE. SUPPLEMENT | - | 4.01 Contributo in Atti di convegno | - |
| A modified Child-Turcotte-Pugh (CTP) for selection of patients affected by cirrhosis candidates for liver transplantation (LT) with low model for end-stage liver disease score (MELD) | S. Gitto, M. Biselli, A. Gramenzi, L. Brodosi, R. Di Donato, G. Vitale, S. Lorenzini, M. Ravaioli..., G. Grazi, A.D. Pinna, M. Bernardi, P. Andreone | 2010-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. | Biselli M; Dall’Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Monta...lti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M. | 2015-01-01 | LIVER INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report. | Gamal N; Brodosi L; Misciali C; Patrizi A; Vukatana G; Malavolta N; Bernardi M; Andreone P. | 2014-01-01 | ANNALS OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers | Mazzotti, Arianna; Caletti, Maria Turchese; Brodosi, Lucia; Di Domizio, Silvia; Forchielli, Maria... Luisa; Petta, Salvatore; Bugianesi, Elisabetta; Bianchi, Giampaolo; Marchesini, Giulio* | 2018-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | Mazzotti-Web_educationNAFLD.pdf |
| Bone marrow derived stem cells for the treatment of end-stage liver disease. | Margini C; Vukotic R; Brodosi L; Bernardi M; Andreone P. | 2014-01-01 | WORLD JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Capitolo 14 "Epatiti Virali Croniche", Volume IX "Malattie del Fegato, delle Vie Biliari e del Pancreas", Trattato di Medicina Interna, fondato da Paolo Larizza | A. Gramenzi; S. Lorenzini; L. Brodosi; P. Andreone | 2010-01-01 | - | Piccin Nuova Libraria | 3.01 Monografia / trattato scientifico in forma di libro | - |
| CD 133+ stem cells for the treatment of end stage liver disease. | L. Brodosi; L. Catani; S. Lorenzini; R. Giordano; S. Rizzi; V. Giudice; D. Sollazzo; B. Nicolini;... E. Montelatici; T. Montemurro; E. Dan; E. Massari; M. Baccarani; M. Bernardi; R. M. Lemoli; P. Andreone. | 2012-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| CD133+ hematopoietic stem cells reinfusion in end-stage liver disease (ESLD): final results of a phase I clinical trial | C. Margini, L. Brodosi, S. Lorenzini, L. Catani, V. Giudice, R. Giordano, A. Casadei, D. Sollazzo..., F.G. Foschi, M. Baccarani, M. Bernardi, R. Lemoli, P. Andreone | 2014-01-01 | JOURNAL OF HEPATOLOGY | - | 4.01 Contributo in Atti di convegno | - |
| CD133+ stem cells for the treatment of end-stage liver disease | L. Brodosi, L. Catani, S. Lorenzini, R. Giordano, S. Rizzi, V. Giudice, D. Sollazzo, B. Nicolini,... E. Montelatici, T. Montemurro, E. Dan, E. Massari, M. Baccarani, M. Bernardi, R.M. Lemoli, P. Andreone | 2012-01-01 | DIGESTIVE AND LIVER DISEASE. SUPPLEMENT | - | 4.01 Contributo in Atti di convegno | - |
| COMBINATION study: COMbined Behavioural/INcretin Action sTudy In Obese/diabetic persoNs | L. Montesi, A. Mazzotti, L. Brodosi, MT Caletti, FA Barbanti, P. Di Bartolo, G. Marchesini | 2018-01-01 | DIABETOLOGIA | - | 4.01 Contributo in Atti di convegno | - |
| Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease | Brodosi L.; Marchignoli F.; Marchesini G.; Petroni M.L. | 2022-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.01 Articolo in rivista | - |
| Dati preliminari sullo studio della sintomatologia ortoressica tra pazienti diabetici affetti da epatopatia. | Brodosi L, Simonetti G, Musio A, Petroni M.L, Gentile A, Genovese M, Marchesini G, Pironi L | 2020-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. | G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, E. Loggi, A....F. Cicero, M. Bernardi, P. Andreone | 2013-01-01 | JOURNAL OF HEPATOLOGY | - | 4.01 Contributo in Atti di convegno | - |
| Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential | Brodosi, Lucia; Musio, Alessandra; Barbanti, Francesca Alessandra; Mita, Dorina; Marchesini, Giul...io; Petroni, Maria Letizia | 2020-01-01 | HEPATOMA RESEARCH | - | 1.01 Articolo in rivista | - |
| Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant) | Brodosi L, Mita D, Simonetti G, Vitale G, Gentile A, Genovese M, Marchesini G, Morelli MC, Pironi L. | 2021-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.01 Contributo in Atti di convegno | - |
| Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis | Colosimo, Santo; Ravaioli, Federico; Petroni, Maria L; Brodosi, Lucia; Marchignoli, Francesca; Ba...rbanti, Francesca A; Sasdelli, Anna S; Marchesini, Giulio; Pironi, Loris | 2021-01-01 | LIVER INTERNATIONAL | - | 1.01 Articolo in rivista | liv.14799-1-1.pdf; liv14799-sup-0001-tables1-s3.docx |
| Fatty liver in pregnancy: a narrative review of two distinct conditions | Azzaroli, Francesco; Mazzella, Giuseppe; Marchesini, Giulio; Brodosi, Lucia; Petroni, Maria Letizia | 2020-01-01 | EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Hepatitis C recurrence after liver transplantation: do patients with mild disease need to be treated? | S. Gitto, L.S. Belli, S. Lorenzini, A. Airoldi, A.F. Cicero, M. Vangeli, L. Brodosi, A.M. Panno, ...R. Di Donato, M. Bernardi, P. Andreone, P | 2012-01-01 | HEPATOLOGY | - | 4.01 Contributo in Atti di convegno | - |
| Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. | Gitto S; Belli LS; Vukotic R; Lorenzini S; Airoldi A; Cicero AF; Vangeli M; Brodosi L; Martello P...anno A; Di Donato R; Cescon M; Grazi GL; De Carlis L; Pinna AD; Bernardi M; Andreone P. | 2015-01-01 | WORLD JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |